Craigavon pharma firm goes global with new Galsana brand launch

Galen, the commercial arm of the Almac Group, set to accelerate growth in rare metabolic disease business

Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city’s Northern Metropolis megaproject. The comments highlighting the city’s international background and pro